Post-infarction Ventricular Septal Defect

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2024-10-10
Clinical Trial Update: The AMPLATZER™ Post-infarct Muscular VSD Occluder Humanitarian Device Exemption (H070005) Post Approval Study
This clinical trial update reports the completion of the humanitarian device exemption post-approval study (H070005) of the AMPLATZER Post-I…